Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 2Weight Loss 1Sexual Dysfunction, Physiological 1Protein Deficiency 1Overweight 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Malnutrition 1Inflammation 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Metformin 2sultamicillin 1semaglutide 1Ursodeoxycholic Acid 1Tirzepatide 1Resistance Training 1Propofol 1Progestins 1Nutrition Assessment 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Exercise 1Exenatide 1Estrogen Replacement Therapy 1Docosahexaenoic Acids 1Cyproterone 1(2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Overweight × Nutrition Assessment × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡